Duforzig 5/10 5mg. 10mg Tablet
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Type 2 diabetes mellitus and heart failure.
Dosage (summary)
10 mg once daily for adults.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin
- Sulfonylureas
Contraindications
- Type 1 diabetes
- Moderate to severe renal impairment
- Pregnancy
- Breastfeeding
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia
Counselling Points
- Monitor for signs of ketoacidosis
- Assess renal function regularly
- Avoid dehydration
Serious warnings
- Risk of metabolic acidosis
- Acute kidney injury
- Risk of dehydration
Important Disclaimer
The Duforzig 5/10 5mg. 10mg Tablet professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
